Economic Costs of Diabetes in the U.S. in 2002
Author(s) -
Paul Hogan,
Timothy M. Dall,
Plamen Nikolov
Publication year - 2003
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/diacare.26.3.917
Subject(s) - medicine , diabetes mellitus , per capita , population , type 2 diabetes , attributable risk , health care , environmental health , disease , indirect costs , gerontology , demography , emergency medicine , endocrinology , business , accounting , sociology , economic growth , economics
Diabetes is the fifth leading cause of death by disease in the U.S. Diabetes also contributes to higher rates of morbidity-people with diabetes are at higher risk for heart disease, blindness, kidney failure, extremity amputations, and other chronic conditions. The objectives of this study were 1). to estimate the direct medical and indirect productivity-related costs attributable to diabetes and 2). to calculate and compare the total and per capita medical expenditures for people with and without diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom